Physician profile
Albert E Zhou
NPI 1821747460
$3,642.05
in general payments reported to CMS, 2019-2025
17 companies · $1,864 in 2025
The $1,864 reported for 2025 was more than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $125 · 2024: $1,653 · 2025: $1,864.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,181 · Education: $461.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,181.14 |
| Education | $460.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Leo Pharma INC. | $858.38 | 2023-2025 | Adbry, Anzupgo |
| Sun Pharmaceutical Industries INC. | $480.64 | 2024-2025 | |
| Regeneron Healthcare Solutions, INC. | $416.01 | 2024-2025 | Dupixent, Libtayo |
| Arcutis Biotherapeutics, INC. | $295.45 | 2024-2025 | Zoryve |
| Janssen Biotech, INC. | $220.97 | 2024-2025 | Tremfya |
| Genzyme Corporation | $201.03 | 2024-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $196.31 | 2024 | Spevigo |
| Novartis Pharmaceuticals Corporation | $143.98 | 2024-2025 | |
| Abbvie INC. | $124.98 | 2025 | |
| Verrica Pharmaceuticals INC. | $124.98 | 2024 | Ycanth |
| Kyowa Kirin, INC. | $118.86 | 2025 | |
| Blueprint Medicines Corporation | $113.62 | 2025 | |
| Galderma Laboratories, L.P. | $109.37 | 2025 | Nemluvio |
| Incyte Corporation | $100.65 | 2025 | |
| Ucb, INC. | $79.29 | 2024 | Bimzelx |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $40.03 | 2025 | |
| Sanara Medtech INC. | $17.50 | 2025 | Celleraterx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Albert Zhou listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.